PRG-A-04 / PRG S&Tech - LARVOL DELTA

Inhibition of SOD1 trimerization is a novel drug target for ALS disease. (PubMed, Transl Neurodegener) - "Our findings underscore the potential of targeting trimeric SOD1 in ALS treatment, positioning PRG-A-04 as a strong drug candidate for both familial and sporadic ALS."

Journal • Amyotrophic Lateral Sclerosis • CNS Disorders • SOD1